NR3C1 and Miyoshi myopathy: Synergistic effects were seen in combination with dexamethasone via the induction of GR expression and inhibition of the mammalian target of rapamycin pathway in MM cells [41], as well as in ex vivo primary MM cells, with MYC‐regulated genes associated with sensitivity to the combination [40].